Hexa Reports Industry Pharmacovigilance (PV) Market

Pharmacovigilance (PV) Market Landscapes Vendor, Status and
Forecasts by Region 2025
“The global Pharmacovigilance (PV) Market is expected to reach USD 10.27
billion by 2025, according to a new report by Hexa Reports. The market is
expected to witness growth at 13.1% CAGR owing to Increasing incidence of
ADR is key driver for the growth of pharmacovigilance market.”
The global Pharmacovigilance (PV) Market is expected to reach USD 10.27 billion by 2025, according to a new
report by Hexa Reports. The market is expected to witness growth at 13.1% CAGR owing to Increasing
incidence of ADR is key driver for the growth of pharmacovigilance market. As of 2015, the U.S. FDA received
approximately 253,017 serious adverse events and 44,693 deaths associated with adverse drug reactions
(ADRs). This shows the potential demand for implementing safety and pharmacovigilance services over the
forecast period.
According to World Health Organization's (WHO) report on pharmaceuticals consumption, medicines to treat
chronic diseases accounted for a larger proportion of the total volume of drug consumption in non-hospital
set ups. Owing to this, there has been a significant rise in the number of medicines made available to
healthcare consumers. Rising demand for drugs has significantly heightened the need for novel therapeutics
development via extensive clinical trials, which is further expected to serve this market with lucrative
opportunities.
Browse Detail Report With TOC @
https://www.hexareports.com/report/pharmacovigilance-pv-market
Follow Us: